242 related articles for article (PubMed ID: 2718192)
1. Antigenic relationships of fractionated western diamondback rattlesnake (Crotalus atrox) hemorrhagic toxins and other rattlesnake venoms as indicated by monoclonal antibodies.
Martinez RA; Huang SY; Perez JC
Toxicon; 1989; 27(2):239-45. PubMed ID: 2718192
[TBL] [Abstract][Full Text] [Related]
2. Comparative enzymatic study of HPLC-fractionated Crotalus venoms.
Soto JG; Perez JC; Lopez MM; Martinez M; Quintanilla-Hernandez TB; Santa-Hernandez MS; Turner K; Glenn JL; Straight RC; Minton SA
Comp Biochem Physiol B; 1989; 93(4):847-55. PubMed ID: 2680253
[TBL] [Abstract][Full Text] [Related]
3. Variation in the antigenic characteristics of venom from the Mojave rattlesnake (Crotalus scutulatus scutulatus).
Huang SY; Perez JC; Rael ED; Lieb C; Martinez M; Smith SA
Toxicon; 1992 Apr; 30(4):387-96. PubMed ID: 1378234
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the immunogenicity and antigenic composition of several venoms of snakes in the family Crotalidae.
Ownby CL; Colberg TR
Toxicon; 1990; 28(2):189-99. PubMed ID: 2339435
[TBL] [Abstract][Full Text] [Related]
5. Production of a monoclonal antibody against hemorrhagic activity of Crotalus atrox (western diamondback rattlesnake) venom.
Perez JC; Garcia VE; Huang SY
Toxicon; 1984; 22(6):967-73. PubMed ID: 6523516
[TBL] [Abstract][Full Text] [Related]
6. The detection of hemorrhagic proteins in snake venoms using monoclonal antibodies against Virginia opossum (Didelphis virginiana) serum.
Sánchez EE; García C; Pérez JC; De La Zerda SJ
Toxicon; 1998 Oct; 36(10):1451-9. PubMed ID: 9723843
[TBL] [Abstract][Full Text] [Related]
7. Regional variation of biochemical characteristics and antigeneity in Great Basin rattlesnake (Crotalus viridis lutosus) venom.
Adame BL; Soto JG; Secraw DJ; Perez JC; Glenn JL; Straight RC
Comp Biochem Physiol B; 1990; 97(1):95-101. PubMed ID: 2174759
[TBL] [Abstract][Full Text] [Related]
8. Partial characterization of a basic protein from Crotalus molossus molossus (northern blacktail rattlesnake) venom and production of a monoclonal antibody.
Sánchez EE; Soliz LA; Ramírez MS; Pérez JC
Toxicon; 2001 Apr; 39(4):523-37. PubMed ID: 11024493
[TBL] [Abstract][Full Text] [Related]
9. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.
Arce V; Rojas E; Ownby CL; Rojas G; Gutiérrez JM
Toxicon; 2003 Jun; 41(7):851-60. PubMed ID: 12782085
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the biological and immunological properties of fractions of prairie rattlesnake (Crotalus viridis viridis) venom.
Ownby CL; Colberg TR
Toxicon; 1987; 25(12):1329-42. PubMed ID: 3125631
[TBL] [Abstract][Full Text] [Related]
11. The hypotensive activity of Crotalus atrox (western diamondback rattlesnake) venom: identification of its origin.
de Mesquita LC; Selistre HS; Giglio JR
Am J Trop Med Hyg; 1991 Mar; 44(3):345-53. PubMed ID: 2035756
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms.
Anderson SG; Gutiérrez JM; Ownby CL
Toxicon; 1993 Aug; 31(8):1051-9. PubMed ID: 8212043
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of two high molecular weight hemorrhagic toxins from Crotalus viridis viridis venom using monoclonal antibodies.
Li Q; Colberg TR; Ownby CL
Toxicon; 1993 Jun; 31(6):711-22. PubMed ID: 8393600
[TBL] [Abstract][Full Text] [Related]
14. Lachesis muta muta venom: immunological differences compared with Bothrops atrox venom and importance of specific antivenom therapy.
Colombini M; Fernandes I; Cardoso DF; Moura-da-Silva AM
Toxicon; 2001 May; 39(5):711-9. PubMed ID: 11072051
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of the hemorrhagic activity of Bothrops and Lachesis snake venoms by a monoclonal antibody against mutalysin-II.
Estêvão-Costa MI; Martins MS; Sánchez EF; Diniz CR; Chávez-Olórtegui C
Toxicon; 2000 Jan; 38(1):139-44. PubMed ID: 10669019
[TBL] [Abstract][Full Text] [Related]
16. A new method for quantitating hemorrhage induced by rattlesnake venoms: ability of polyvalent antivenom to neutralize hemorrhagic activity.
Ownby CL; Colberg TR; Odell GV
Toxicon; 1984; 22(2):227-33. PubMed ID: 6729841
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-linked immunosorbant assay (ELISA) of size-selected crotalid venom antigens by Wyeth's polyvalent antivenom.
Schaeffer RC; Randall H; Resk J; Carlson RW
Toxicon; 1988; 26(1):67-76. PubMed ID: 3347932
[TBL] [Abstract][Full Text] [Related]
18. The distribution among ophidian venoms of a toxin isolated from the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus).
Weinstein SA; Minton SA; Wilde CE
Toxicon; 1985; 23(5):825-44. PubMed ID: 3937297
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four different immunogens for the production of snake antivenoms.
Li Q; Ownby CL
Toxicon; 1992 Nov; 30(11):1319-30. PubMed ID: 1485332
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the protective effect of a commercially available western diamondback rattlesnake toxoid vaccine for dogs against envenomation of mice with western diamondback rattlesnake (Crotalus atrox), northern Pacific rattlesnake (Crotalus oreganus oreganus), and southern Pacific rattlesnake (Crotalus oreganus helleri) venom.
Cates CC; Valore EV; Couto MA; Lawson GW; McCabe JG
Am J Vet Res; 2015 Mar; 76(3):272-9. PubMed ID: 25710764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
